“…In fact, in 2018, the Substance Abuse and Mental Health Services Administration started to provide funding for medical schools willing to adjust their curriculum to fulfill waiver training requirements, but only one school has done so [ 10 ]. Some recent pilot studies in the United States have shown that integrating waiver training for medical students does increase knowledge, interest, and confidence in diagnosing and treating OUD [ 16 , 17 ], and calls attention to the need for a standardized, nationwide course, as there is currently none. A key advantage of GW courses is that even though the requirements for buprenorphine prescription have been relaxed, GW can provide mentorship and education in a brief, free, virtual, and interactive setting that boosts confidence and arms clinicians with the tools they need to effectively use their X waiver.…”